![]() | ![]() |
Formats:
|
||||||||||||||||||
Copyright © 2008, Cold Spring Harbor Laboratory Press A genome-scale analysis of the cis-regulatory circuitry underlying sonic hedgehog-mediated patterning of the mammalian limb 1 Department of Molecular and Cellular Biology, Harvard University, Cambridge, Massachusetts 02138, USA; 2 Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland 21205, USA; 3 Department of Statistics, Stanford University, Stanford, California, 94305, USA; 4 Harvard Stem Cell Institute, Harvard University, Cambridge, Massachusetts 02138, USA 5Present address: Section of Molecular Cell and Developmental Biology, Institute for Cellular and Molecular Biology, The University of Texas at Austin, 2500 Speedway, Austin, TX 78712, USA. 6Corresponding author.E-MAIL mcmahon/at/mcb.harvard.edu; FAX (617) 496-3763. Received May 8, 2008; Accepted August 5, 2008. This article has been cited by other articles in PMC.Abstract Sonic hedgehog (Shh) signals via Gli transcription factors to direct digit number and identity in the vertebrate limb. We characterized the Gli-dependent cis-regulatory network through a combination of whole-genome chromatin immunoprecipitation (ChIP)-on-chip and transcriptional profiling of the developing mouse limb. These analyses identified ~5000 high-quality Gli3-binding sites, including all known Gli-dependent enhancers. Discrete binding regions exhibit a higher-order clustering, highlighting the complexity of cis-regulatory interactions. Further, Gli3 binds inertly to previously identified neural-specific Gli enhancers, demonstrating the accessibility of their cis-regulatory elements. Intersection of DNA binding data with gene expression profiles predicted 205 putative limb target genes. A subset of putative cis-regulatory regions were analyzed in transgenic embryos, establishing Blimp1 as a direct Gli target and identifying Gli activator signaling in a direct, long-range regulation of the BMP antagonist Gremlin. In contrast, a long-range silencer cassette downstream from Hand2 likely mediates Gli3 repression in the anterior limb. These studies provide the first comprehensive characterization of the transcriptional output of a Shh-patterning process in the mammalian embryo and a framework for elaborating regulatory networks in the developing limb. Keywords: Sonic hedgehog, limb, morphogen, gli, cis-regulatory network The vertebrate limb is one of the best studied models of how morphogen signaling elaborates a complex pattern (for review, see McGlinn and Tabin 2006). Shh secreted by a discrete posterior organizing center, the zone of polarizing activity (ZPA), is thought to act as a long-range, concentration-dependent signal that regulates both the number and identity of digits that arise from the distal mesenchyme of the developing limb bud. Both the concentration and time of Shh signaling are critical, and growth couples with morphogen activity to give the final digit pattern (Yang et al. 1997; Harfe et al. 2004; Towers et al. 2008; Zhu et al. 2008). Shh actions are mediated through the Gli transcriptional effector family (Gli1-3). Of these, Gli3 appears to play a crucial role in regulating digit number; loss of Gli3 repressor leads to polydactyly and suppresses the loss of digits (2–5) observed in Shh mutants (Litingtung et al. 2002; te Welscher et al. 2002b). Interactions between the limb mesenchyme and the apical ectodermal ridge (AER) are critical for digit development. The Shh pathway is thought to maintain the limb outgrowth-promoting role of AER produced FGFs through the regulation of a BMP antagonist, Gremlin (Zuniga et al. 1999; Khokha et al. 2003). In turn, AER signaling is essential for maintaining Shh expression (Laufer et al. 1994; Niswander et al. 1994). Genetic analyses have suggested that Shh-mediated loss of Gli3 repressor activity underlies the Shh → Gremlin → AER circuit, but whether this is a direct action of Gli repressor has not been addressed (Litingtung et al. 2002; te Welscher et al. 2002b). How digits are regulated at the transcriptional level is less clear. Genetic studies have indicated a close interaction between members of the 5′HoxD complex, which have been implicated in the regulation of digit identity and Shh. Initially, 5′HoxD activity is required for the onset of Shh expression (Tarchini et al. 2006). However, as the digit field emerges, HoxD members become targets of Shh regulation. How is not clear, but the identification of a global control region (GCR) outside of the HoxD complex suggests an interaction with this distal regulatory element. Shh also regulates expression of Bmp2 within the distal, digit-forming limb mesenchyme, and experiments modulating BMP levels in the chick have suggested that Bmp2 may act as a secondary relay to regulate digit identity (Dahn and Fallon 2000; Drossopoulou et al. 2000). However, genetic studies in the mouse have not supported this view (Bandyopadhyay et al. 2006); consequently, the precise roles of BMPs are contentious. We attempted to understand the roles of Shh signaling by identifying the targets of Gli3 action in the developing mouse limb. These studies provide a framework for the primary regulatory networks downstream from Shh signaling and identify new links between Shh and other signaling pathways in driving limb outgrowth. In addition to identifying targets of Gli repression regulating critical outputs in the developmental program, our work demonstrates that the Gli activator forms play a critical role in the limb patterning circuitry. Results In a previous study, we developed an approach to conditionally produce a Flag-tagged form of a Gli activator and examined Hedgehog (Hh) action in patterning neural progenitors in vitro (Vokes et al. 2007). Here, we introduced a cDNA encoding a Flag-epitope-tagged Gli3 repressor (Yuen et al. 2006) into the ubiquitous Rosa26 promoter to enable Cre-dependent conditional expression in Hh target regions in vivo (see the Materials and Methods; Supplemetnal Fig. S1A–C). When RosaGli3TFlag c/c mice were crossed to mice carrying the early limb mesenchyme-specific Prrx1 Cre transgene (Logan et al. 2002), they produce Gli3TFlag at levels that are comparable with the endogenous protein (Supplemental Fig. S1C). Mice exhibited a variety of limb defects including a variable preaxial forelimb polydactyly, limb truncation, and reduced mineralization (Supplemental Fig. S1D). These phenotypes suggest that Gli3TFlag is active and modifies both Shh action in initial limb patterning and later Indian hedgehog action in growth and differentiation of the endochondral skeleton.To focus our analysis on the period of Shh-mediated regulation of distal digit organization, we optimized a chromatin immunoprecipitation (ChIP) protocol to enable the direct identification of Gli3 targets in limb buds at embryonic day 11.5 (E11.5). A high level of enrichment of Gli target genes was obtained using ~2.3 × 106 cells per ChIP. Three technical replicates comprising all limbs from a single litter (approximately nine embryos) provided sufficient sample for the interrogation of multiple tiling arrays required for a whole-genome hybridization. Data was processed using CisGenome software (http://www.biostat.jhsph.edu/~hji/cisgenome; H. Ji, H. Jiang, W. Ma, D.S. Johnson, R.M. Myers, and W.H. Wong, in prep.), identifying 20,587 potential Gli-binding regions (GBRs) with an estimated false discovery rate (FDR) of 9.8% (Supplemental Table S1). The GBRs were binned according to rank and the overall Gli enrichment level was obtained for each bin. Bins containing a Gli enrichment level of ≥2 were selected, reducing the list to the top 19,732 scoring regions (FDR < 5%) (Fig. 1A
Genomic topography and binding site clustering Analysis of ChIP products discovered a substantial enrichment in Gli motif sites within GBRs consistent with our expectations (Vokes et al. 2007). In all, 55% of these regions contain a high-quality Gli motif. Those GBRs exhibiting the highest levels of fold enrichment also contain the highest percentage of Gli motif enrichment (Fig. 1B The high percentage of GBRs (45%) that did not contain a Gli-binding motif may reflect an indirect mechanism (e.g., Gli3-dependent protein–protein interactions with another DNA-binding protein or a nonphysiological DNA association). When the overall rate of sequence conservation was compared, GBRs without Gli motifs were, in fact, somewhat more conserved (Fig. 1D
To determine whether GBRs containing Gli motifs cluster, we computed the pairwise distance between directly neighboring binding regions and compared this with randomly chosen Gli motifs from the genome (Ji et al. 2006). This analysis demonstrates that GBRs are not randomly distributed but cluster at the 100-kb scale (Fig. 1E Gli3 recognizes homologous and heterologous enhancers A previous analysis of Shh action on neural progenitors identified 25 biologically significant Gli1-binding sites (Vokes et al. 2007). Among these are neural specific Shh target genes (FoxA2, Nkx2-2, Nkx2-9, and Titf1/Nkx2.1) and more general targets of the pathway (Ptch1, Ptch2, Hhip, Rab34, and Gli1) that are also expressed in the limb. Gli3 bound to each of the general targets in the limb (with multiple inputs confirmed for Ptch1) to similar regions observed by Gli1 in neural progenitors (Table 2). In all, the set of 5274 GBRs included 16/25 neural Gli1-binding regions (four more were in the 19,732 GBR data set) with the surprising inclusion of neural-specific Gli1-binding regions. Thus, cis-binding regions mediating neural-specific regulation of a Gli program are accessible to Gli factors in the limb. However, the binding of Gli3 to the above characterized neural-specific Gli enhancers appears to be nonfunctional (Table 2; Fig. 2A,E
Identification of a core set of Shh-responsive limb gli target genes In order to define a core set of Shh-responsive direct target genes in the limb, we associated Gli3-binding sites with Shh-dependent transcriptional responses. Using exon arrays, we compared wild-type E11.5 forelimbs with forelimbs from Shh-null (constitutive Gli repressor), MhoxCre;R26SmoM2 (maximal Gli activation) (Jeong et al. 2004), Gli3-null (loss of major repressor), and Smo;Gli3 double mutant (loss of Gli activator and Gli repressor) backgrounds. In addition, we profiled E11.5 forelimbs microdissected into an anterior 1/3 compartment (Ant) or posterior 2/3-d compartment (Post); Gli1 expression in the posterior sample defines the active Shh signaling domain (Fig. 3A
To determine if a meaningful association would be made between GBRs and differentially expressed genes, we counted the number of GBRs associated with Shh-responsive genes and compared it with binding sites associated with randomly selected genes to define an FDR. Significantly more binding regions were associated with Shh-responsive genes (Supplemental Fig. S4A). Those GBRs located within a region 10 kb upstream of and 25 kb downstream from the TSS of differentially regulated genes showed a FDR of 50%. As an independent measure of the significance of binding regions associated with differentially expressed genes, we examined their conservation levels. GBRs associated with differentially expressed genes are significantly more conserved out to a distance of >1 Mb, albeit with a very high FDR (Supplemental Fig. S4B). Thus, our initial strategy likely underestimates the total number of associated GBRs. To further optimize this association, we noted that genes associated with development and transcription are enriched within gene deserts that are devoid of coding regions (Ovcharenko et al. 2005). Consistent with this, Gli3 peaks associated with differentially expressed genes have fewer intervening TSSs than randomly chosen genes (Supplemental Fig. S4C). We therefore incorporated information about the gene density into the final FDR determination (Supplemental Fig. S4D). We supplemented this list by searching for clustered binding regions and intersected these with differentially expressed genes (see the Materials and Methods). The pooled data identified 656 GBR–gene pairs, involving 656 GBRs and 261 genes. We further restricted our criteria for direct target genes to those associated with the binding regions containing Gli motifs (Fig. 3B
Discovery of DNA motifs enriched in GBRs To determine whether any additional transcription factor-binding sites were enriched in Gli-containing binding regions and to identify sites enriched in non-Gli-containing regions, we performed de novo motif analysis using a Gibbs motif sampler (GMS) as described previously (Ji et al. 2006; Vokes et al. 2007). In addition to a Gli motif, we recovered two G/C-rich motifs (Table 1); a similar sequence has been observed in other large-scale ChIP analyses (Ji et al. 2006). We also identified a composite motif specifically enriched in Gli-binding sites that do not contain Gli motifs. This motif contained an E-box indicative of basix helix–loop–helix (bHLH) homeodomain transcription factor binding fused to an ATTA motif, the core binding site for homeodomain transcription factors (FDR = 39%). However, as this motif was enriched within the larger subset of GBRs not associated with Shh modulated gene expression (Table 1), the significance to Gli3 regulation in the limbs is not clear. We also mapped all TRANSFAC human and mouse motifs to GBRs relative to matched genomic controls. Using this criteria, we found variants of an E-box enriched in limb GBRs with or without Gli motifs. Further, Mef2 and Chx10 motifs were specifically enriched in limb peaks devoid of Gli motifs (Supplemental Table S3). The core TAAT sequences in the Chx10 homeodomain factor is consistent with the composite E-box + Homeobox motif discussed above. Functional characterization of Gli cis-regulatory elements In order to explore the contributions of GBRs, we selected those associated with a number of genes that display distinct expression within the limb for functional transgenic analysis. Gli1 is a transcriptional activator and a global target of Gli activator response in all known Hh target fields (Bai et al. 2004). An unusually broad, bimodal GBR (3.7 kb) is observed in Gli1 intronic sequences that span the first noncoding exon (Fig. 3C Blimp1 (Prdm1) encodes a DNA-binding protein that recruits chromatin modifiers and plays a central role in the regulation of several stem/progenitor cell populations (Ohinata et al. 2005; Horsley et al. 2006). Blimp1 is expressed in the ZPA where its activity is required to maintain the ZPA and, consequently, normal Shh production (Robertson et al. 2007). A single GBR containing two Gli motifs was identified ~27 kb downstream from the Blimp1 transcriptional unit (Fig. 3G Gremlin encodes a BMP antagonist that is postulated to act downstream from Shh to maintain the AER. Consequently, Gremlin mutants lose Shh expression as the AER to ZPA feedback loop is broken and fail to develop distal limb structures (Zuniga et al. 1999; Khokha et al. 2003). In contrast to Blimp1, Gremlin expression is excluded from the ZPA but extends throughout most of the distal limb mesenchyme (Fig. 4C Comparison of Shh−/− and Shh−/−; Gli3−/− compound mutants has suggested that Shh regulates Gremlin through the loss of Gli3 repressor rather than by a Gli activator function (Fig. 4D–F Hand2 encodes a transcriptional regulator that acts genetically upstream of Shh to positively regulate Shh expression. In turn, Hand2 is restricted posteriorly by Gli3-mediated repression (Fig. 4J,K To address the former possibility, the 10K + 85K binding regions were attached to a Prrx1 regulatory cassette; this contains a strong limb enhancer that drives broad mesenchymal expression of transgenes in the limb (see schematic Fig. 4M lacZ expression is somewhat variable (nine of 14 transgenics exhibit limb expression), all embryos with limb expression showed approximately similar levels of β-galactosidase activity in both the anterior and posterior limb mesenchyme (Fig. 4Ncis-regulatory mechanisms of Shh-dependent AP patterning in the limb bud The 656 GBRs associated with 205 genes showing Shh/Gli-regulated expression changes provide a foundation for dissecting the Gli cis-regulatory circuitry in limb development. The Gli1, Blimp1, Gremlin, and Hand2 analyses functionally validate the data set. However, a full validation through transgenic experiments is not feasible. To shed further light on novel regulatory interactions, we examined a subset of genes that exhibit the most pronounced asymmetry in their anterior versus posterior expression through computational analysis of the gene expression data (see Supplemental Table S6). Whereas only 14% of randomly chosen genes are associated with GBRs, the posterior gene set contains 35 genes, 23 of which are closely associated with GBRs (Supplemental Table S6). The core Shh pathway components Gli1, Ptch1 and Ptch2 are all present. As these require Gli activator input, these data likely represent Gli activator targets where Shh signaling levels are highest and provide further evidence that Gli repressor and activator forms recognize common targets. In addition to Hand2 discussed above, the posterior set includes a large number of transcription factors with known roles in limb development: Hand2 (discussed above), Tbx2 (early role in initiating Shh expression) (Nissim et al. 2007), Hoxd13 (skeletal patterning) (Zakany and Duboule 1996), Sall1 (limb abnormality mirroring that seen in Townes-Brocks syndrome (Kiefer et al. 2003)), and Tbx4 (hindlimb outgrowth (Naiche and Papaioannou 2007). Further, the identification of BMP (Bmp2) and Notch (Dlk1) pathway components may point to cross-regulatory interactions in signaling pathways. In contrast, only eight of the anterior gene set (31 genes) are associated with GBRs (Supplemental Table S6). The lower number is consistent with a largely repressive role of Gli3 in the anterior limb bud. Remarkably, of the 11 transcription factors in this set, six of them associated with GBRs: Pax1, Alx4, Pax9, Zic3, Irx3, and Dlx5. Alx4 mutants exhibit polydactyly (Qu et al. 1997), and Dlx5 is a candidate gene for split-hand/split-foot malformation (Robledo et al. 2002). Further, Alx4 and Pax9 expression is Gli3-dependent—both are down-regulated on loss of Gli3 activity (te Welscher et al. 2002a; McGlinn et al. 2005). This suggests that in certain cellular contexts, Gli3 binding to a regulatory region may indirectly promote anterior expression, perhaps by blocking the action of some other repressive function. However, analysis of one of these genes, Alx4, has identified a regulatory region that recapitulate Gli3-dependent expression and this region shows no GBRs in our data set (Kuijper et al. 2005). Discussion In this study we attempted to define the complete set of in vivo binding sites for a mammalian transcription factor in the context of a specific developmental process, Shh-mediated patterning of the limb. The methodology is sensitive requiring relatively low numbers of cells (~2.3 × 106 cells per ChIP) and the general strategy of a genetically inducible epitope-tagged transcription factor is broadly applicable to other Hh-mediated regulatory events and other transcriptional networks. We detect ~20,000 GBRs, focusing our analysis on a subset of ~5000 GBRs that are greater than six standard deviations from the mean. The substantial enrichment of Gli motifs within this population gives credence to the view that these are most likely to include biologically significant regulatory regions. While it is likely that some sites are missed, for example, where Gli3 binding occurs within a subpopulation of limb mesenchyme below the threshold of detection, the numbers of binding sites are consistent with genome scale studies in mammalian cell culture (Carroll et al. 2006; Yang et al. 2006; Johnson et al. 2007). Currently this represents the only large-scale data set for GBRs. The data incorporate a more limited set of 25 Gli1-binding regions identified in Shh patterning of neural tissue (Table 2), indicating that Gli activator and repressor forms have similar binding specificities in vivo as they exhibit in vitro (Kinzler and Vogelstein 1990; Hallikas et al. 2006; Vokes et al. 2007). These include neural specific target genes that are transcriptionally silent in the limb. Thus, their GBRs are accessible to Gli factors but Gli3 activity is not required for tissue-specific silencing. In light of this result, it is likely that a significant fraction of the GBRs may reflect genes regulated by Hh signals in other tissue contexts. Indeed, only 696 of the 5274 GBRs (12.4%) associate with Shh pathway-regulated genes in the limb. Whereas some of these may reflect genes regulated at earlier or later stages of limb development, a large number are probably “inert” binding sites as observed in whole-genome studies in Drosophila (Li et al. 2008). Transgenic analyses of regulatory networks within mammalian systems have demonstrated that considerable distances often separate cis-regulatory regions from the TSSs they modulate and regulatory regions may lie 5′ or 3′ of a gene’s promoter. Existing promoter arrays contain cis-regulatory sequences that are relative close to the TSS (e.g., −7.5 kb upstream to +2.5 kb from the TSS). Because of this proximity, most studies have assumed that binding of a regulatory factor within this proximal domain associates with the regulation of that gene; they do not attempt to measure an explicit FDR. In whole-genome studies such as ours, however, the indeterminate distance between genes and their cognate regulatory regions makes assigning long-range binding sites a nontrivial problem. We estimated the FDR associated with varying distances and find that by including information about both the gene density of the region and clustering tendencies of binding regions, we are able to make and then validate predictions for direct Gli input into long-range cis-elements that are likely to regulate Gremlin (>100 kb from the 3′ end of the transcriptional unit), Blimp1 (>25 kb from the 3′ end of the transcriptional unit) and Hand2 (10 kb and 85 kb downstream from the transcriptional unit). Of the 656 GBRs associated with differentially expressed limb genes, 252 are ≥20 kb from a TSS with an FDR <50% (Supplemental Data Set 3). Thus, longer-range cis-regulatory interactions are relatively common in this Gli3 regulatory network and likely more generally in mammalian systems. Gli regulatory circuitry and modes of Gli action Our analysis of several Gli3-binding regions in mediating cis-regulatory control of endogenous target genes validate the approach and data set, providing interesting new insights into cross-regulatory mechanisms that contribute to limb patterning. In the mouse, Blimp1 expression precedes Shh (Vincent et al. 2005) and analysis of Blimp1 mutants indicates that Blimp1 regulates Shh levels (Robertson et al. 2007). Our results suggest that a Shh–Gli regulatory input plays a reciprocal role in maintaining Blimp1 expression, a feedback mechanism essential for forming the most posterior digits (Robertson et al. 2007). In the pectoral fin of the zebrafish, Shh is also required for maintenance, but not induction, of Blimp1. Further, Shh lies genetically upstream of Blimp1-mediated regulation of slow twitch muscle fibers (Baxendale et al. 2004; Lee and Roy 2006). Given the critical role of Blimp1 in several stem/progenitor cell compartments and Shh’s roles in maintenance of stem/progenitor cells, we speculate that this regulatory module may play a broader role in other tissues. Two major signaling pathways are specifically enriched among target genes of Gli regulation; as expected, the Hh pathway itself where feedback systems play in important role in modulating activity and output, and the BMP pathway (Supplemental Table S5). BMP signaling plays a crucial role in regulating limb outgrowth through the AER (see above) and is postulated to play a role in patterning digit identity when signaling is modulated in the chick limb (Dahn and Fallon 2000; Drossopoulou et al. 2000). However, removal of BMP activity in the mouse mesenchyme gives a normal range of digits but supernumerary preaxial and post-axial digits (Selever et al. 2004; Bandyopadhyay et al. 2006). We identify both Bmp2 and Gremlin as direct targets and provide functional evidence for the Shh–Gremlin interaction. A GBR >100 kb downstream from the gene encoding this critical BMP antagonist mediates a direct Gli activator activity in the posterior half of the normal Gremlin expression domain. Interestingly, although our data clearly demonstrate a Gli activator role, derepression of Gli3 in Shh−/−; Gli3−/− (Litingtung et al. 2002; te Welscher et al. 2002b) or Smo−/−;Gli3−/− (Fig. 4E
Our analysis suggests a model where Gli3 acts through a cis-acting silencer region to directly repress Hand2; Shh signaling attenuates Gli3 repressor production (Wang et al. 2000) enabling the maintenance of Hand2 expression in the posterior limb mesenchyme. The predicted silencer likely interacts with positive acting elements located outside of the GBR assayed. Chromosome capture conformation studies will likely shed important light on this and many other long-range interactions mediating Gli regulatory function. Further, new methodologies will likely improve silencer analysis, almost certainly an artificially underestimated component of regulatory networks. Future studies The present analysis provides a regulatory scaffold for the construction of Gli-dependent subcircuits in limb development (Fig. 5 Materials and methods Generation of mouse strains and ChIP-on-chip We generated a cDNA encoding a truncated form of mouse Gli3 containing the first 740 amino acids of mouse Gli3 (a gift from Dr. Ulrich Rüther) to make a Gli3 repressor (Gli3T) with a C-terminal 3XFlag epitope (Sigma). Gli3T was targeted to the Rosa26 locus (Supplemental Fig. S1A; Soriano 1999) in YFP3.1 embryonic stem (ES) cells (Supplemental Fig. S1B–C) (Mao et al. 2005) to generate a Cre-inducible Gli3 repressor line. Rosa Gli3TFlagc/c females mice were crossed with Prrx1Cre homozygous males and litters were assayed at E11.5. ChIP and LMPCR was performed as described previously (Vokes et al. 2007) with minor modifications (see the Supplemental Material) and DNA products were hybridzed to the Mouse Tiling 2.0R 7 array set or Mouse Promoter 1.0R array (single samples). The Histone H3K27Me3 antibody (Abcam ab6002) was incubated with anti-mouse IgG beads (Dynal #112.01) and the Pan Histone H3 antibody (Abcam ab1791) with anti-rabbit IgG beads (Dynal #112.03). ChIPs were processed as above using a single nonpooled ChIP from one litter of wild-type (Swiss-Webster) anterior or posterior limb fractions (two biological replicates). These were assayed on Affymetrix Mouse Promoter 1.0R arrays. Probes in Affymetrix tiling arrays were remapped to the mm8 build 36 version of the mouse genome—all coordinates in this study are reported in mm8. Raw data were quantile-normalized and binding regions were determined using the new version of TileMap incorporated into CisGenome using a moving average (MA) (see the Supplemental Material; Ji and Wong 2005). All expression and tiling array data associated with this study have been deposited to the GEO database (GSE11062 and GSE11063). Exon gene expression arrays All gene expression experiments used E11.5 forelimbs. Samples were hybridized to Mouse Exon 1.0ST arrays (Affymetrix). The data were normalized and gene level expression indices were computed using GeneBASE software (Xing et al. 2006; Kapur et al. 2007). We then generated the following pairwise comparisons using PowerExpress, which implements the gene selection methods described in Paik et al. (2007): Shh < wild type; SmoM2 > wild type; Gli3 < wild type; Gli3 > wild type; Ant < Post; Ant > Post. Genes with an FDR ≤10% and a fold change ≥2 were selected. We did not generate pairwise comparisons for a certain combinations with SmoGli3 and Gli3 mutants because data from these arrays contained significant variability. To identify additional genes that were Shh-responsive, we performed the following multiple sample comparisons using an FDR ≤10% and a posterior probability cutoff of ≤25%: (1) Ant < Post and Shh < wild type < SmoM2, (2) Ant < Post and Shh < wild type < SmoM2 and Gli3 > SmoGli3, (3) Ant < Post and Shh < wild type < SmoM2 and wild type > SmoGli3. To define polarized gene sets representing both anterior and posterior compartments, we used the gene expression data on dissected anterior and posterior limb buds, Shh mutant limb buds, and SmoM2 limb buds (see Supplemental Table S6). Assignment of Gli target genes To calculate an initial intersection of binding regions with expression data, we identified 753 genes differentially expressed in at least one of the pairwise or multivariable comparisons in the exon array data. We counted the number of GBRs located within a given distance of their TSS, and we compared the observed number with random expectations (see the Supplemental Material; Supplemental Fig. S4A). To incorporate information about intervening transcripts (gene density), each of the 5274 GBRs was associated with a gene encoding the closest differentially expressed transcript. We counted the number of GBR–gene pairs separated by ≤Wbp and ≤K intervening promoters and compared the observed number with random expectations (see the Supplemental Material; Supplemental Fig. S4D). In order to explore binding regions located further away from genes, we collected the 689 GBRs in the 123 binding clusters reported in Figure 1F Transgenic experiments To test for enhancer activity, we first visually scanned the annotated GBRs and adjusted fragment size in an attempt to recover an entire cis-regulatory domain based on visual inspection of conserved sequence using MultiZ alignments. These extended GBRs were PCR amplified inserted into pHSP68lacZ2XINS (Vokes et al. 2007) (coordinates are described in the Supplemental Material). The Hand2 constructs were tested for repressive activity in pSilencer, a modified version of pBSMhox—a precursor construct for Prx1Cre (Logan et al. 2002)—where a LacZ expression cassette was inserted downstream from the Prrx1 regulatory sequences that drive limb expression (Fig. 4P Acknowledgments We thank Zhenjuan Wang and Manfred Baetscher (Harvard Genome Modification Facility) for pronuclear injections; Benjamin Allen, Jennifer Couget (FAS Center for Systems Biology), Joshua Mugford, Joo-Seop Park, and Courtney Yuen for advice; Yi Xing and Karen Kapur for providing exon array analysis software and expertise; Baolin Wang for providing the Gli3 antibody; and Renate Hellmiss for help with figures. Alex Schier and Cliff Tabin provided helpful advice either during the project or on the manuscript. We acknowledge support from the Helen Hay Whitney Foundation and Charles A. King Trust, Bank of America, Co-Trustee (Boston, MA) (to S.A.V.); the JHSPH Richard Gelb Faculty Innovation Award (to H.J.); and funding from the NIH, HG003903 (to A.P.M. and W.H.W.) and NS033642 (to A.P.M.). Footnotes Supplemental material is available at http://www.genesdev.org. Article is online at http://www.genesdev.org/cgi/doi/10.1101/gad.1693008. References
|
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||||
Curr Opin Genet Dev. 2006 Aug; 16(4):426-32.
[Curr Opin Genet Dev. 2006]Development. 1997 Nov; 124(21):4393-404.
[Development. 1997]Cell. 2004 Aug 20; 118(4):517-28.
[Cell. 2004]Nature. 2008 Apr 17; 452(7189):882-6.
[Nature. 2008]Dev Cell. 2008 Apr; 14(4):624-32.
[Dev Cell. 2008]Nature. 1999 Oct 7; 401(6753):598-602.
[Nature. 1999]Nat Genet. 2003 Jul; 34(3):303-7.
[Nat Genet. 2003]Cell. 1994 Dec 16; 79(6):993-1003.
[Cell. 1994]Nature. 1994 Oct 13; 371(6498):609-12.
[Nature. 1994]Nature. 2002 Aug 29; 418(6901):979-83.
[Nature. 2002]Nature. 2006 Oct 26; 443(7114):985-8.
[Nature. 2006]Science. 2000 Jul 21; 289(5478):438-41.
[Science. 2000]Development. 2000 Apr; 127(7):1337-48.
[Development. 2000]PLoS Genet. 2006 Dec; 2(12):e216.
[PLoS Genet. 2006]Development. 2007 May; 134(10):1977-89.
[Development. 2007]J Am Chem Soc. 2006 Jul 12; 128(27):8939-46.
[J Am Chem Soc. 2006]Genesis. 2002 Jun; 33(2):77-80.
[Genesis. 2002]Development. 2007 May; 134(10):1977-89.
[Development. 2007]Development. 2007 May; 134(10):1977-89.
[Development. 2007]Nucleic Acids Res. 2006; 34(21):e146.
[Nucleic Acids Res. 2006]Development. 2007 May; 134(10):1977-89.
[Development. 2007]Dev Biol. 2006 Dec 15; 300(2):623-34.
[Dev Biol. 2006]Development. 2007 May; 134(10):1977-89.
[Development. 2007]Genes Dev. 2004 Apr 15; 18(8):937-51.
[Genes Dev. 2004]Cell. 2001 Jun 1; 105(5):599-612.
[Cell. 2001]Genome Res. 2005 Jan; 15(1):137-45.
[Genome Res. 2005]Dev Biol. 2007 Apr 1; 304(1):9-21.
[Dev Biol. 2007]Nucleic Acids Res. 2006; 34(21):e146.
[Nucleic Acids Res. 2006]Development. 2007 May; 134(10):1977-89.
[Development. 2007]Dev Cell. 2004 Jan; 6(1):103-15.
[Dev Cell. 2004]J Biol Chem. 1999 Mar 19; 274(12):8143-52.
[J Biol Chem. 1999]Nature. 2005 Jul 14; 436(7048):207-13.
[Nature. 2005]Cell. 2006 Aug 11; 126(3):597-609.
[Cell. 2006]Development. 2007 Dec; 134(24):4335-45.
[Development. 2007]Cell. 2004 Aug 20; 118(4):517-28.
[Cell. 2004]Nature. 1999 Oct 7; 401(6753):598-602.
[Nature. 1999]Nat Genet. 2003 Jul; 34(3):303-7.
[Nat Genet. 2003]Science. 2004 Jul 16; 305(5682):396-9.
[Science. 2004]Genes Dev. 2004 Jul 1; 18(13):1553-64.
[Genes Dev. 2004]Nature. 2002 Aug 29; 418(6901):979-83.
[Nature. 2002]Development. 2000 Jun; 127(11):2461-70.
[Development. 2000]Genesis. 2000 Apr; 26(4):225-9.
[Genesis. 2000]Dev Biol. 2007 Apr 1; 304(1):9-21.
[Dev Biol. 2007]Nature. 1996 Nov 7; 384(6604):69-71.
[Nature. 1996]Hum Mol Genet. 2003 Sep 1; 12(17):2221-7.
[Hum Mol Genet. 2003]Development. 2007 Jan; 134(1):93-103.
[Development. 2007]Development. 1997 Oct; 124(20):3999-4008.
[Development. 1997]Genes Dev. 2002 May 1; 16(9):1089-101.
[Genes Dev. 2002]Mech Dev. 2005 Nov; 122(11):1218-33.
[Mech Dev. 2005]Dev Biol. 2005 Sep 15; 285(2):533-44.
[Dev Biol. 2005]Nat Genet. 2006 Nov; 38(11):1289-97.
[Nat Genet. 2006]Mol Cell. 2006 Nov 17; 24(4):593-602.
[Mol Cell. 2006]Science. 2007 Jun 8; 316(5830):1497-502.
[Science. 2007]Mol Cell Biol. 1990 Feb; 10(2):634-42.
[Mol Cell Biol. 1990]Cell. 2006 Jan 13; 124(1):47-59.
[Cell. 2006]Development. 2007 May; 134(10):1977-89.
[Development. 2007]PLoS Biol. 2008 Feb; 6(2):e27.
[PLoS Biol. 2008]Development. 2007 Dec; 134(24):4335-45.
[Development. 2007]Nat Genet. 2004 Jan; 36(1):88-93.
[Nat Genet. 2004]Dev Biol. 2006 Dec 15; 300(2):623-34.
[Dev Biol. 2006]Science. 2000 Jul 21; 289(5478):438-41.
[Science. 2000]Development. 2000 Apr; 127(7):1337-48.
[Development. 2000]Dev Biol. 2004 Dec 15; 276(2):268-79.
[Dev Biol. 2004]PLoS Genet. 2006 Dec; 2(12):e216.
[PLoS Genet. 2006]Nature. 2002 Aug 29; 418(6901):979-83.
[Nature. 2002]Cell. 2000 Feb 18; 100(4):423-34.
[Cell. 2000]Nat Genet. 1998 Dec; 20(4):325-6.
[Nat Genet. 1998]Development. 2004 May; 131(10):2339-47.
[Development. 2004]Curr Biol. 2007 Mar 20; 17(6):545-50.
[Curr Biol. 2007]Nat Genet. 1999 Jan; 21(1):70-1.
[Nat Genet. 1999]Nucleic Acids Res. 2005 Oct 12; 33(18):e155.
[Nucleic Acids Res. 2005]Development. 2007 May; 134(10):1977-89.
[Development. 2007]Bioinformatics. 2005 Sep 15; 21(18):3629-36.
[Bioinformatics. 2005]PLoS One. 2006 Dec 20; 1():e88.
[PLoS One. 2006]Genome Biol. 2007; 8(5):R82.
[Genome Biol. 2007]Cell. 2007 Jan 26; 128(2):309-23.
[Cell. 2007]Development. 2007 May; 134(10):1977-89.
[Development. 2007]Genesis. 2002 Jun; 33(2):77-80.
[Genesis. 2002]